General Information of the Compound
Compound ID
CP0509464
Compound Name
4-tert-butyl-N-(1H-indol-4-yl)-1,3-thiazol-2-amine
    Show/Hide
Synonyms
CHEMBL207479
N-(4-tert-butylthiazol-2-yl)-1H-indol-4-amine
SCHEMBL5966378
    Show/Hide
Structure
Formula
C15H17N3S
Molecular Weight
271.389
Canonical SMILES
CC(C)(C)c1csc(Nc2cccc3[nH]ccc23)n1
    Show/Hide
InChI
InChI=1S/C15H17N3S/c1-15(2,3)13-9-19-14(18-13)17-12-6-4-5-11-10(12)7-8-16-11/h4-9,16H,1-3H3,(H,17,18)
    Show/Hide
InChIKey
ITGYBDHDFLFUCN-UHFFFAOYSA-N
Physicochemical Property
logP
4.6655
Rotatable Bonds
2
Heavy Atom Count
19
Polar Areas
40.71
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
3
Complexity
19

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 21866574
ChEMBL ID
CHEMBL207479
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01508, C-C chemokine receptor type 4
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000108 CCRF-CEM Homo sapiens (Human)  1
1
IC50 = 490 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( N-(4-tert-butylthiazol-2-yl)-1H-indol-4-amine )
Drug Name N-(4-tert-butylthiazol-2-yl)-1H-indol-4-amine
Target(s)
C-C chemokine receptor type 4 (CCR4)
Inhibitor